Evidence map›Paper›PMID 28034301›Full record

ArticleRetrovirology2016

Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition.

Klara Post, Erik D Olson, M Nabuan Naufer, Robert J Gorelick, Ioulia Rouzina, Mark C Williams, Karin Musier-Forsyth, Judith G Levin

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Animal models for studies of HIV-1 brain reservoirs.Journal of leukocyte biology · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Protein-nucleic acid interactions of LINE-1 ORF1p.Seminars in cell & developmental biology · 2019
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Klara PostSection on Viral Gene Regulation, Program in Genomics of Differentiation, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20892-2780, USA.
Erik D OlsonDepartment of Chemistry and Biochemistry, Center for Retrovirus Research, and Center for RNA Biology, The Ohio State University, Columbus, OH, 43210, USA.
M Nabuan NauferDepartment of Physics, Northeastern University, Boston, MA, 02115, USA.
Robert J GorelickAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, 21702-1201, USA.
Ioulia RouzinaDepartment of Chemistry and Biochemistry, Center for Retrovirus Research, and Center for RNA Biology, The Ohio State University, Columbus, OH, 43210, USA.
Mark C WilliamsDepartment of Physics, Northeastern University, Boston, MA, 02115, USA. ma.williams@northeastern.edu.ORCID http://orcid.org/0000-0003-3219-376X
Karin Musier-ForsythDepartment of Chemistry and Biochemistry, Center for Retrovirus Research, and Center for RNA Biology, The Ohio State University, Columbus, OH, 43210, USA. musier-forsyth.1@osu.edu.
Judith G LevinSection on Viral Gene Regulation, Program in Genomics of Differentiation, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20892-2780, USA. levinju@mail.nih.gov.ORCID http://orcid.org/0000-0002-6327-8216
The Ohio State University · USNational Institutes of Health · USNortheastern University · USLeidos (United States) · US

Funding

RNA Binding and Packaging By Retroviral Gag ProteinsR01GM065056 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MUSIER-FORSYTH, KARIN M · 2002 to 2018
$4.9M
Single Molecule HIV-1 Replication InteractionsR01GM072462 · NIGMS · NORTHEASTERN UNIVERSITY · PI WILLIAMS, MARK C · 2004 to 2018
$3.9M
CHEMISTRY/BIOLOGY TRAINING GRANTT32GM008512 · NIGMS · OHIO STATE UNIVERSITY · PI PEI, DEHUA · 1996 to 2016
$3.9M
MINOS (Macromolecular Insights on Nucleic acids Optimized by Scattering)R01GM105404 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI TAINER, JOHN A. · 2012 to 2015
$2.1M
Mechanism of HIV-1 gRNA-Gag interaction leading to selective genome packagingF31AI120868 · NIAID · OHIO STATE UNIVERSITY · PI OLSON, ERIK DAVID · 2016 to 2017
$64k
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENIAID NIH HHS F31 AI120868NIGMS NIH HHS R01 GM065056NIGMS NIH HHS R01 GM072462NIGMS NIH HHS R01 GM105404NIGMS NIH HHS T32 GM008512
6 · The paper itself

Abstract

backgroundThe nucleocapsid (NC) domain of HIV-1 Gag is responsible for specific recognition and packaging of genomic RNA (gRNA) into new viral particles. This occurs through specific interactions between the Gag NC domain and the Psi packaging signal in gRNA. In addition to this critical function, NC proteins are also nucleic acid (NA) chaperone proteins that facilitate NA rearrangements during reverse transcription. Although the interaction with Psi and chaperone activity of HIV-1 NC have been well characterized in vitro, little is known about simian immunodeficiency virus (SIV) NC. Non-human primates are frequently used as a platform to study retroviral infection in vivo; thus, it is important to understand underlying mechanistic differences between HIV-1 and SIV NC.

resultsHere, we characterize SIV NC chaperone activity for the first time. Only modest differences are observed in the ability of SIV NC to facilitate reactions that mimic the minus-strand annealing and transfer steps of reverse transcription relative to HIV-1 NC, with the latter displaying slightly higher strand transfer and annealing rates. Quantitative single molecule DNA stretching studies and dynamic light scattering experiments reveal that these differences are due to significantly increased DNA compaction energy and higher aggregation capability of HIV-1 NC relative to the SIV protein. Using salt-titration binding assays, we find that both proteins are strikingly similar in their ability to specifically interact with HIV-1 Psi RNA. In contrast, they do not demonstrate specific binding to an RNA derived from the putative SIV packaging signal.

conclusionsBased on these studies, we conclude that (1) HIV-1 NC is a slightly more efficient NA chaperone protein than SIV NC, (2) mechanistic differences between the NA interactions of highly similar retroviral NC proteins are revealed by quantitative single molecule DNA stretching, and (3) SIV NC demonstrates cross-species recognition of the HIV-1 Psi RNA packaging signal.

Indexed as

Genome, Viralgag Gene Products, Human Immunodeficiency VirusHIV-1HumansMolecular ChaperonesNucleic Acid ConformationNucleocapsid ProteinsProtein BindingReverse TranscriptionRNA, ViralSimian Immunodeficiency Virusgag Gene Products, Human Immunodeficiency VirusMolecular ChaperonesNucleocapsid ProteinsRNA, ViralHIV-1Minus-strand transferNucleic acid bindingNucleic acid chaperone activityNucleocapsid proteinsPsi RNA packaging signalReverse transcriptionSingle molecule DNA stretchingSIVSmall angle X-ray scattering

Identifiers

PMID28034301
PMCPMC5198506
OpenAlexW2562023473

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.